Camp4 Therapeutics (CAMP) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to -$0.55.
- Camp4 Therapeutics' EPS (Weighted Average and Diluted) rose 9772.63% to -$0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was $63.67, marking a year-over-year increase of 15953.81%. This contributed to the annual value of -$11.04 for FY2024, which is 9115.17% up from last year.
- Latest data reveals that Camp4 Therapeutics reported EPS (Weighted Average and Diluted) of -$0.55 as of Q3 2025, which was up 9772.63% from -$0.62 recorded in Q2 2025.
- Camp4 Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.55 during Q3 2025, with a 5-year trough of -$30.18 in Q4 2023.
- In the last 3 years, Camp4 Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$24.19 in 2024 and averaged -$15.64.
- As far as peak fluctuations go, Camp4 Therapeutics' EPS (Weighted Average and Diluted) skyrocketed by 1718.59% in 2024, and later soared by 9772.63% in 2025.
- Camp4 Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$30.18 in 2023, then surged by 90.62% to -$2.83 in 2024, then skyrocketed by 80.57% to -$0.55 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.55 in Q3 2025, compared to -$0.62 in Q2 2025 and -$0.62 in Q1 2025.